Asthma Treatment Market Forecast Highlights Expansion From $24.86 Billion To $29.49 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Asthma Treatment Market Growth Potential: How Will Market Size Change Through 2030?
The asthma treatment market has experienced consistent expansion over the past few years. Valued at $23.75 billion in 2025, it is projected to reach $24.86 billion by 2026, reflecting a compound annual growth rate (CAGR) of 4.7%. This historical growth has been driven by factors such as the rising global incidence of asthma, dependence on short-acting beta-agonists (SABA), insufficient understanding of maintenance therapies, widespread use of traditional inhalers, and the broadening of hospital pharmacy networks.
The asthma treatment market is projected to experience consistent expansion over the coming years, reaching an estimated value of $29.49 billion by 2030, with a compound annual growth rate (CAGR) of 4.4%. This anticipated growth during the forecast period is driven by factors such as the development of novel biologics and ultra therapies, the uptake of digital inhalers and smart monitoring systems, the growth of online pharmacy distribution channels, heightened awareness regarding combination therapies, and increased investment in personalized medicine along with patient adherence programs. Key trends shaping the forecast period include a growing preference for biologics and targeted therapies, a greater reliance on combination drugs for managing asthma, the rise of home-based and remote monitoring devices, the expansion of both online and retail pharmacy outlets, and a stronger emphasis on creating individualized asthma management strategies.
Download A Free Sample Report For Comprehensive Market Insights:
Asthma Treatment Market Expansion Drivers: What Is Shaping Future Growth?
The anticipated growth of the asthma treatment market is significantly driven by the increasing incidence of respiratory disorders. These conditions, which include chronic obstructive pulmonary disease (COPD), bronchitis, and asthma, are defined by their impact on lung function and breathing. A primary factor behind the surge in respiratory disorders is air pollution, where substances like particulate matter and nitrogen oxides inflame and irritate airways, causing breathing difficulties and exacerbating asthma. This growing prevalence fuels the demand for asthma management strategies, encompassing medications, inhalers, and lifestyle adjustments to control symptoms and airway inflammation. For example, the National Library of Medicine, a US-based institution, reported in December 2023 that COPD cases in low- and middle-income countries are forecast to more than double those in high-income nations by 2050, with sub-Saharan Africa anticipated to see a 59% rise and lead the world in COPD prevalence and cases by 2040. Thus, the rising frequency of respiratory disorders is propelling the expansion of the asthma treatment market.
Asthma Treatment Market Categorization By Product Type And Application
The asthma treatment market covered in this report is segmented –
1) By Treatment: Long-Term Control Medications, Quick-Relief Medications
2) By Device Type: Inhalers, Dry Powder, Metered Dose, Soft Mist Nebulizers
3) By Drug Class: Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Other Drug Class
4) By Route Of Administration: Oral, Inhaled, Intravenous, Subcutaneous
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines, Biologics
2) By Quick-Relief Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics
Asthma Treatment Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major players in the asthma treatment sector are channeling their efforts into creating breakthrough solutions, including anti-inflammatory rescue inhalers, designed to deliver fast symptom relief while simultaneously tackling the root cause of airway inflammation in individuals with asthma. These anti-inflammatory rescue inhalers are specifically defined as devices that offer immediate relief from asthma symptoms through their rescue function, while also working to reduce airway inflammation via their anti-inflammatory action during an asthma episode. A notable example occurred in January 2024 when AstraZeneca, a biopharmaceutical firm based in the United Kingdom, introduced AIRSUPRA (albuterol/budesonide)—a pioneering inhaler for asthma management. This product stands as the first and only FDA-approved fixed-dose combination that merges albuterol, a short-acting beta2-agonist (SABA), with budesonide, an inhaled corticosteroid (ICS), formulated to serve as a rescue medication for asthma. It provides quick bronchodilation while concurrently addressing airway inflammation during asthma flare-ups, effectively handling both symptoms and the underlying inflammatory process with a single dose. Targeted at patients aged 18 and over, this inhaler promotes enhanced overall asthma control and diminishes the need for separate controller therapies.
Asthma Treatment Market Company Landscape And Strategic Competition
Major companies operating in the asthma treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A., Cipla Limited.
Access The Complete Asthma Treatment Market Report:
Asthma Treatment Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the asthma treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
